Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Validation of Computerized Quantification of Ocular Redness.

Sirazitdinova E, Gijs M, Bertens CJF, Berendschot TTJM, Nuijts RMMA, Deserno TM.

Transl Vis Sci Technol. 2019 Dec 12;8(6):31. doi: 10.1167/tvst.8.6.31. eCollection 2019 Nov.

2.

In vitro and in vivo datasets of topically applied ketorolac tromethamine in aqueous humor using Raman spectroscopy.

Zhang S, Bertens CJF, Erckens RJ, van den Biggelaar FJHM, Berendschot TTJM, Webers CAB, Nuijts RMMA, Gijs M.

Data Brief. 2019 Oct 22;27:104694. doi: 10.1016/j.dib.2019.104694. eCollection 2019 Dec.

3.

Confocal Raman spectroscopy: Evaluation of a non-invasive technique for the detection of topically applied ketorolac tromethamine in vitro and in vivo.

Bertens CJF, Zhang S, Erckens RJ, van den Biggelaar FJHM, Berendschot TTJM, Webers CAB, Nuijts RMMA, Gijs M.

Int J Pharm. 2019 Oct 30;570:118641. doi: 10.1016/j.ijpharm.2019.118641. Epub 2019 Aug 22.

PMID:
31446026
4.

Topical drug delivery devices: A review.

Bertens CJF, Gijs M, van den Biggelaar FJHM, Nuijts RMMA.

Exp Eye Res. 2018 Mar;168:149-160. doi: 10.1016/j.exer.2018.01.010. Epub 2018 Jan 17. Review.

PMID:
29352994
5.

Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.

Gijs M, Penner G, Blackler GB, Impens NR, Baatout S, Luxen A, Aerts AM.

Pharmaceuticals (Basel). 2016 May 19;9(2). pii: E29. doi: 10.3390/ph9020029.

6.

Aptamers as radiopharmaceuticals for nuclear imaging and therapy.

Gijs M, Aerts A, Impens N, Baatout S, Luxen A.

Nucl Med Biol. 2016 Apr;43(4):253-71. doi: 10.1016/j.nucmedbio.2015.09.005. Epub 2015 Sep 28. Review.

PMID:
26746572
7.

Gallium-68-labelled NOTA-oligonucleotides: an optimized method for their preparation.

Gijs M, Dammicco S, Warnier C, Aerts A, Impens NR, D'Huyvetter M, Léonard M, Baatout S, Luxen A.

J Labelled Comp Radiopharm. 2016 Feb;59(2):63-71. doi: 10.1002/jlcr.3363. Epub 2015 Dec 29.

PMID:
26712111
8.

Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.

D'Huyvetter M, Aerts A, Xavier C, Vaneycken I, Devoogdt N, Gijs M, Impens N, Baatout S, Ponsard B, Muyldermans S, Caveliers V, Lahoutte T.

Contrast Media Mol Imaging. 2012 Mar-Apr;7(2):254-64. doi: 10.1002/cmmi.491.

PMID:
22434639

Supplemental Content

Loading ...
Support Center